Radiofrequency ablation of atrial flutter with 1:1 accessory pathway conduction improved cardiac function in a patent with PRKAG2 Cardiomyopathy. Insights with 68Ga-FAPI PET/CT imaging.

Abstract excerpt

PRKAG2 syndrome is an autosomal dominant cardiac glycogenosis caused by mutations in the PRKAG2 gene, clinically characterized by the triad of ventricular hypertrophy, conduction disease, and ventricular pre-excitation, along with a high propensity for supraventricular arrhythmias. This report describes a young male carrier of the R302Q mutation who developed wide QRS tachycardia due to atrial flutter with 1:1...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to AMP-Activated Protein Kinases
• Share to Catheter Ablation